AQT-001 (AQUAGOLD®)
Device for personalized intradermal delivery of therapeutic agents for skin conditions
CommercialActive
Key Facts
Indication
Device for personalized intradermal delivery of therapeutic agents for skin conditions
Phase
Commercial
Status
Active
Company
About Aquavit Pharmaceuticals
Aquavit Pharmaceuticals is a clinical-stage biotech company pioneering personalized healthcare via advanced delivery platforms. Its core assets include DTX-021, a botulinum toxin in development for aesthetic and therapeutic indications, and the commercial AQUAGOLD® microchannel delivery device. The company leverages a network of high-profile clinical investigators and is progressing DTX-021 through the FDA regulatory pathway, with recent IND clearances marking a key transition into clinical trials. Its strategy targets the large and growing neuromodulator and precision dermatology markets.
View full company profile